Ping An Insurance (Group) Company of China, Ltd. has released its 2025 annual report. The company achieved an operating profit attributable to shareholders of the parent company of 134.415 billion yuan, representing a year-on-year increase of 10.3%. The Group's net profit attributable to parent company shareholders reached 134.778 billion yuan, up 6.5% from the previous year.

Shareholders' equity attributable to the parent company surpassed the 1 trillion yuan mark for the first time, reaching 1.000419 trillion yuan, a 7.7% increase from the beginning of 2025. The company's insurance funds investment portfolio grew to 6.49 trillion yuan by the end of 2025, an increase of 13.2% from the start of the year.

Ping An's dividend payout saw significant growth. The company proposed a final dividend of 1.75 yuan per share for 2025, bringing the full-year cash dividend to 2.7 yuan per share, a 5.9% increase year-on-year. The total cash dividend distribution amounted to 48.891 billion yuan, marking the 14th consecutive year of dividend growth.

The life and health insurance business demonstrated strong performance, with new business value surging 29.3% to 36.897 billion yuan. The new business value margin reached 28.5%, an improvement of 5.8 percentage points. By distribution channel, the agent channel saw new business value grow by 10.4%, while the bancassurance channel experienced remarkable growth of 138%.

The company's healthcare and retirement ecosystem has become a significant growth driver. Clients using medical and elderly care services showed a 4 percentage point increase in additional policy purchase rates. The average premium for new life insurance policies was 1.5 times higher for clients with healthcare benefits, 5.2 times higher for those with home-based elderly care benefits, and 23.4 times higher for clients with high-quality retirement benefits.

Ping An's healthcare subsidiary, Ping An Health, achieved revenues of 5.468 billion yuan with a net profit of 380 million yuan in 2025. The company has developed AI-powered products including digital doctor avatars, AI family physicians, and AI retirement managers, covering over 11,300 diseases with a diagnostic accuracy rate of 95.1%.